Reduced intensity stem cell transplantation with targeted BU from unrelated donor for chronic granulomatous disease-Reference-Cited by-同舟云学术

Reduced intensity stem cell transplantation with targeted BU from unrelated donor for chronic granulomatous disease

Published:2017 Issue:4 Volume:6 Page:152-156
ISSN:2186-5612
Container-title:Journal of Hematopoietic Cell Transplantation
language:en
Short-container-title:Journal of Hematopoietic Cell Transplantation

Author:

Shirai Ryota¹,Osumi Tomoo¹,Yamada Yuji¹,Goto Fumihiro²,Nakazawa Yumiko²,Shioda Yoko¹,Kiyotani Chikako¹,Terashima Keita¹,Imadome Ken-Ichi³,Matsumoto Kana⁴,Morita Kunihiko⁴,Uchiyama Toru²,Kawai Toshinao²,Onodera Masafumi²,Tomizawa Daisuke¹,Kato Motohiro¹,Matsumoto Kimikazu¹

Affiliation:

1. Children’s Cancer Center, National Center for Child Health and Development, Tokyo, Japan

2. Department of Immunology, National Center for Child Health and Development, Tokyo, Japan

3. Department of Advanced Medicine for Infections, National Center for Child Health and Development, Tokyo, Japan

4. Department of Clinical Pharmaceutics, Faculty of Pharmaceutical Sciences, Doshisha Women’s College of Liberal Arts

Publisher

The Japan Society for Hematopoietic Stem Cell Transplantation

Subject

General Medicine

Link

https://www.jstage.jst.go.jp/article/hct/6/4/6_16-019/_pdf

Reference9 articles.

1. 1. Ahlin A, Fugelang J, de Boer M, et al. Chronic granulomatous disease-haematopoietic stem cell transplantation versus conventional treatment. Acta paediatrica (Oslo, Norway: 1992). 2013; 102: 1087-1094.

2. 2. Japan, P. I. D. i. http://pidj.rcai.riken.jp/medical_guideline091221.html. 2016 May 10;

3. 3. Seger RA, Gungor T, Belohradsky BH, et al. Treatment of chronic granulomatous disease with myeloablative conditioning and an unmodified hemopoietic allograft: a survey of the European experience, 1985-2000. Blood. 2002; 100: 4344-4350.

4. 4. Horwitz ME, Barrett AJ, Brown MR, et al. Treatment of chronic granulomatous disease with nonmyeloablative conditioning and a T-cell-depleted hematopoietic allograft. N Engl J Med. 2001; 344: 881-888.

5. 5. Hasegawa D, Fukushima M, Hosokawa Y, et al. Successful treatment of chronic granulomatous disease with fludarabine-based reduced-intensity conditioning and unrelated bone marrow transplantation. Int J Hematol. 2008; 87: 88-90.